Drug Shortage Report for FOSAVANCE

Last updated on 2023-09-14 History
Report ID 196834
Drug Identification Number 02314940
Brand name FOSAVANCE
Common or Proper name alendronate sodium / cholecalciferol tablets
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) VITAMIN D3 ALENDRONIC ACID
Strength(s) 5600UNIT 70MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 4
ATC code M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-06-26
Estimated end date 2023-09-15
Actual end date 2023-09-13
Shortage status Resolved
Updated date 2023-09-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-09-14 English Compare
v10 2023-09-13 French Compare
v9 2023-09-13 English Compare
v8 2023-09-01 French Compare
v7 2023-09-01 English Compare
v6 2023-08-25 French Compare
v5 2023-08-25 English Compare
v4 2023-07-31 French Compare
v3 2023-07-31 English Compare
v2 2023-06-29 French Compare
v1 2023-06-29 English Compare

Showing 1 to 11 of 11